(RYTM) Rhythm Pharmaceuticals - Performance 100.6% in 12m
RYTM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
69.57%
#5 in Peer-Group
Rel. Strength
93.67%
#487 in Stock-Universe
Total Return 12m
100.63%
#14 in Peer-Group
Total Return 5y
328.49%
#5 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 89.04 USD |
| 52 Week Low | 43.56 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 99.49 |
| Buy/Sell Signal +-5 | -1.69 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RYTM (100.6%) vs XBI (-7.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
4.78% | 72% | 82.5% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.68% | -8.84% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.37% | -3.61% | 40.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.33% | 33.2% | -0.68% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
8.13% | -8.29% | 7.01% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
14.7% | 39.8% | -2.94% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.29% | 55.9% | -6.21% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.06% | 28.4% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: RYTM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RYTM
| Total Return (including Dividends) | RYTM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 32.17% | 3.64% | 4.08% |
| 3 Months | 53.97% | 23.43% | 19.65% |
| 12 Months | 100.63% | -7.41% | 12.88% |
| 5 Years | 328.49% | -20.74% | 113.48% |
| Trend Score (consistency of price movement) | RYTM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 47.8% | 30.3% | 86.9% |
| 3 Months | 48.7% | 79.4% | 97.2% |
| 12 Months | 76.2% | -87.3% | 46% |
| 5 Years | 67.9% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th92.00 | 27.52% | 26.99% |
| 3 Month | %th74.50 | 24.74% | 28.68% |
| 12 Month | %th93.00 | 116.68% | 77.74% |
| 5 Years | %th99.00 | 440.59% | 100.71% |
FAQs
Does Rhythm Pharmaceuticals (RYTM) outperform the market?
Yes,
over the last 12 months RYTM made 100.63%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.41%.
Over the last 3 months RYTM made 53.97%, while XBI made 23.43%.
Performance Comparison RYTM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RYTM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 35.3% | 28.1% | 50.1% | 88% |
| US NASDAQ 100 | QQQ | 35.5% | 28.1% | 48.7% | 90% |
| German DAX 40 | DAX | 33.2% | 30.3% | 38% | 68% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 33.9% | 26.9% | 45.7% | 80% |
| Hongkong Hang Seng | HSI | 36.5% | 29.7% | 29.8% | 64% |
| India NIFTY 50 | INDA | 36.3% | 32.2% | 50.6% | 103% |
| Brasil Bovespa | EWZ | 40.8% | 30.3% | 34.1% | 98% |
RYTM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 36.6% | 30% | 46.6% | 78% |
| Consumer Discretionary | XLY | 35.3% | 29.7% | 57.8% | 84% |
| Consumer Staples | XLP | 36.7% | 32.3% | 51% | 93% |
| Energy | XLE | 33.4% | 27% | 56.5% | 98% |
| Financial | XLF | 36.3% | 28.6% | 46.3% | 73% |
| Health Care | XLV | 34.8% | 31.2% | 60.1% | 106% |
| Industrial | XLI | 34.5% | 27.3% | 43% | 75% |
| Materials | XLB | 34.4% | 27.9% | 46.7% | 94% |
| Real Estate | XLRE | 35.8% | 32.8% | 50.7% | 89% |
| Technology | XLK | 35.4% | 25.3% | 45.8% | 92% |
| Utilities | XLU | 34.5% | 29.4% | 47.7% | 78% |
| Aerospace & Defense | XAR | 35% | 25.7% | 31.9% | 52% |
| Biotech | XBI | 31.7% | 28.5% | 59.7% | 108% |
| Homebuilder | XHB | 32% | 23.8% | 54.4% | 95% |
| Retail | XRT | 35% | 29.4% | 55.6% | 90% |
RYTM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 35.1% | 26.9% | 65.0% | 107% |
| Natural Gas | UNG | 38.7% | 40.3% | 78.4% | 106% |
| Gold | GLD | 35.7% | 32.3% | 35.2% | 61% |
| Silver | SLV | 34.7% | 30.6% | 36.3% | 81% |
| Copper | CPER | 26.3% | 18.8% | 29.1% | 78% |
RYTM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 35.4% | 30.5% | 54.5% | 103% |
| iShares High Yield Corp. Bond | HYG | 35.7% | 30.9% | 53.5% | 91% |